Back to Search

BRITTIN THIBODEAUX, MD

MD

Obstetrics & Gynecology Physician

NPI: 1124656236IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

341387(LA)

Education

OTHER

Class of 2020

Research & Publications (18)

Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
PMID 15287370·Curr Eye Res·2004
4-observational
Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies.
PMID 19297614·Clin Vaccine Immunol·2009
7-preclinical
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
PMID 17453960·Curr Eye Res·2007
7-preclinical
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
PMID 16421016·Curr Eye Res·2006
7-preclinical
Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.
PMID 14628143·Med Microbiol Immunol·2005
7-preclinical
Pathogenesis of Staphylococcus in the rabbit anterior chamber.
PMID 15790904·Invest Ophthalmol Vis Sci·2005
7-preclinical
Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
PMID 16186360·Invest Ophthalmol Vis Sci·2005
7-preclinical
Comparison of bacterial inoculation and transcutaneous oxygen tension in the rabbit S1 perforator and latissimus dorsi musculocutaneous flaps.
PMID 15739152·J Reconstr Microsurg·2005
4-observational
Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.
PMID 15516485·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
PMID 15155183·Antimicrob Agents Chemother·2004
4-observational
Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases.
PMID 14744894·Invest Ophthalmol Vis Sci·2004
7-preclinical
Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation.
PMID 12419815·J Biol Chem·2003
8-other
Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida.
PMID 12506074·Invest Ophthalmol Vis Sci·2003
7-preclinical
Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
PMID 12454041·Invest Ophthalmol Vis Sci·2002
7-preclinical
Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
PMID 12410042·Cornea·2002
4-observational
Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
PMID 11685070·Cornea·2001
4-observational
Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
PMID 11584345·Curr Eye Res·2001
4-observational
The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
PMID 11821987·Curr Eye Res·2001
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4640 AMBASSADOR CAFFERY PKWY BLDG B
LAFAYETTE, LA 70508

Location

Practice Location

4640 AMBASSADOR CAFFERY PKWY BLDG B, LAFAYETTE, LA
(337) 984-1050

Quick Facts

NPI
1124656236
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
6
Publications
18

Are you this provider?

Claim Your Profile